ZBTB7A and glioblastoma: By analyzing gene expression databases, Kyung-Chul Choi and Seong Who Kim at the University of Ulsan College of Medicine in Seoul, South Korea, and co-workers found that expression of a regulatory protein, the transcription factor ZBTB7A, is significantly reduced in patients with aggressive GBM.